vimarsana.com
Home
Live Updates
Not Advisable To Intervene In Matters Lacking Anti-Competit
Not Advisable To Intervene In Matters Lacking Anti-Competit
Not Advisable To Intervene In Matters Lacking Anti-Competitive Conduct, CCI Dismisses complaint against Pharma Entities
The Competition Commission of India (CCI) bench, consisting of Ms Ravneet Kaur (Chairperson), Mr Anil Agrawal (Member), Ms Sweta Kakkad (Member), and Mr Deepak Anurag (Member), held that in the...
Related Keywords
India ,
Somnath Banerjee ,
Patent Office ,
Standards Authority Of India ,
Competition Commission Of India ,
Apex Lab ,
Indian Drug Manufacturer Association ,
Reserca Health Care Pvt ,
Observations Of The Commission ,
Brief Facts ,
Competition Commission ,
Competition Act ,
Reserca Health Care ,
Sales Representatives ,
Food Safety ,
Standards Authority ,
Opposite Parties ,
Competition Commission Of India Cci ,
Anti Competitive ,
Purchase ,
Sale ,
Commercial Considerations ,
Losed Information ,
Pharmaceutical Entities ,